Narrowband UVB Phototherapy Treatment: Safe, Effective, & Versatile
Phothera is a leading manufacturer of FDA-cleared narrowband UVB phototherapy devices for home and clinical use. Built on the combined expertise of Daavlin and National Biological Corporation (NatBio), Phothera brings more than 80 years of experience to the treatment of chronic skin conditions. NB-UVB phototherapy has a well-established safety profile, with adverse events generally limited to mild, transient erythema.
Bring Proven Phototherapy into Modern Dermatology Workflows
Dermatologists have relied on narrowband ultraviolet B (NB-UVB) phototherapy for decades to treat psoriasis, vitiligo, and cutaneous T-cell lymphoma (CTCL), with phototherapy remaining a first-line treatment in American Academy of Dermatology (AAD) guidelines. For Eczema (atopic dermatitis), phototherapy is an important option when topical treatments are insufficient.
Phothera helps make prescribing and managing phototherapy simple with tools, like convenient EMR integrations and digital prescription submissions, designed to support you, your practice, and your patients.
Why Dermatologists Choose NB-UVB Phototherapy with Phothera
Reduce reliance on systemic medications:
A non-systemic treatment option for psoriasis, vitiligo, CTCL, and atopic dermatitis.
Improved adherence with home phototherapy:
Guided Mode devices include protocols with built-in safety guardrails and demonstrated 3x higher adherence in the 783-patient LITE clinical trial.1
Simplify prescribing and workflow:
Compatible with Epic® and EMA® to support prescribing and documentation.
Expanded patient access and coverage:
Broad insurance coverage with up to $0 cost for eligible patients, helping remove financial barriers to treatment.
Phototherapy can be administered in-office or at-home, making it a versatile & widely adaptable treatment choice.
At-Home Phototherapy
- Prescribed by your dermatologist and designed for safe home treatment
- Guided Mode with on-device app and AAD treatment protocols built in
- 3x higher adherence compared with standard home therapy (LITE Study, n=783)1
- Broad insurance coverage with $0 cost for eligible patients*
- EMR-compatible prescribing with Epic® and EMA®
*$0 patient cost applies to eligible insured patients. Not all patients will qualify.
In-Office Phototherapy
- Clinical phototherapy devices designed for dermatology practices
- Covered by most major insurance providers
- Expand treatment offerings within your practice
- Recommended in national dermatology treatment guidelines
Proven narrowband UVB therapy, delivered in the setting that meets your patient’s needs.
See the Clinical Evidence: Phothera Phototherapy Before and After
Acutal patient using an at-home device (100 model), week 1 vs. week 7. Individual results may vary.
The Prescribing Process Made Easy
Write a prescription for home phototherapy (NBUVB) and specify the indication.
Submit via EMA®, Epic®, or the Phothera E-Form — choose the method that works best for your practice.
Phothera Cares handles prior authorization, claims, and appeals to support broader patient access.
Eligible insured patients pay as little as $0*.
Device shipped, free of charge, directly to the patient’s home.
A New, Faster Way to Connect With Phothera
Our dedicated provider line gives you direct access to support for Phothera prescriptions, patients, and devices.
1-844-676-2882 (1-844-67-NBUVB)
- Orders, prior authorization, and shipping status
- Refills and treatment unlocks
- Insurance, coverage, and billing
- Technical support
- Prescription forms and documentation
- Dosing questions and clinical guidance
- Account setup and operational support
Introducing the new Phothera status tracker–a simple way for you, your staff, and your patients to track the prescription status from submission to fulfillment, all in one place.
I was fortunate to have a dermatologist that noticed the treatments in his office were transformative for me. He didn’t hesitate to order a light therapy box for my home & I have been so happy to be in charge of my own treatments.
– Gordon (phototherapy patient)
The Phothera Advantage: 5 Benefits of Narrowband UVB Phototherapy
CLINICAL CONFIDENCE
Established safety and efficacy backed by decades of clinical evidence.
PROVEN RESULTS
High rates of clearance, including 95.1% reported in clinical studies.
TREATMENT FLEXIBILITY
In-office, home, or dual-path treatment options tailored to your practice and patients.
PRACTICE OPPORTUNITY
Expand access to phototherapy while supporting consistent equipment utilization.
PATIENT ACCESS
Phothera Cares helps reduce financial barriers and manages the administrative burden of access.
Enhance Patient Care & Grow Your Practice
Phototherapy has the unique ability to expand a provider’s patient population by attracting individuals with chronic skin conditions seeking effective and safe treatments. Its versatility allows for both in-office sessions and home use options, accommodating diverse lifestyles and preferences. By integrating phototherapy, providers can meet the growing demand for innovative therapeutic skincare solutions with a highly effective treatment strategy for patients making it a valuable opportunity for clinics everywhere.
I am a firm believer that phototherapy is key to the success of any dermatological practice as it provides a safe & effective treatment solution for a variety of chronic skin conditions.
– Dr. David B Vasily, M.D.
Learn how Phothera can help you.
REFERENCES:
- Gelfand JM et al., JAMA Dermatol. 2024; doi:10.1001/jamadermatol.2024.3897
- Jury CS, McHenry P, Burden AD, Lever R, Bilsland D. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol. 2006 Mar;31(2):196-9. doi: 10.1111/j.1365-2230.2006.02061.x. PMID: 16487089.
- Myers E, Kheradmand S, Miller R. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases. Cureus. 2021 Nov 1;13(11):e19182. doi: 10.7759/cureus.19182. PMID: 34873522; PMCID: PMC8634827.
- Bulur, I., Erdogan, H. K., Aksu, A. E., Karapınar, T., & Saracoglu, Z. N. (2018). The efficacy and safety of phototherapy in geriatric patients: a retrospective study. Anais brasileiros de dermatologia, 93(1), 33–38. https://doi.org/10.1590/abd1806-4841.20185468.
- Rácz, E., & Prens, E. P. (2017). Phototherapy of psoriasis, a chronic inflammatory skin disease. Advances in Experimental Medicine and Biology, 287–294. https://doi.org/10.1007/978-3-319-56017-5_24.